EPO Patents = 1

Forward Citations = 38

Loading Chart...

4 inventors (with patents filed for the assignee):

Christopher P Rusconi (8 out of 24 patents)

Douglas Brooks (3 out of 6 patents)

Juliana Layzer (3 out of 6 patents)

4. Steven Zelenkofske (3 out of 3 patents)

8 patents: Sort by Forward Citations

1. 8889646 - Nucleic acid modulators of glycoprotein VI (2014-11-18),

2. 8889645 - Nucleic acid modulators of glycoprotein VI (2014-11-18),

3. 8859518 - Modulators of coagulation factors (2014-10-14),

4. 8389489 - Modulators of coagulation factors (2013-03-05),

5. 8318923 - Nucleic acid modulators of glycoprotein VI (2012-11-27),

6. 7723315 - Modulators of coagulation factors (2010-05-25),

7. 7531524 - Modulators of coagulation factors with enhanced stability (2009-05-12),

8. 7304041 - Modulators of coagulation factors (2007-12-04),

Regado Biosciences, Inc. is a biopharmaceutical company focused on developing novel therapeutics for acute cardiovascular conditions. The company's lead product candidate is an injectable anticoagulant designed to provide improved control and safety for patients undergoing procedures such as angioplasty. Regado's innovative approach has the potential to change the standard of care in acute cardiovascular settings.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

8 Patents

#19 in Basking Ridge, NJ

#1,332 in New Jersey

#34,852 in US

Basking Ridge, NJ, United States of America

Regado Biosciences, Inc.

Forward Citations = 38

4 inventors:

Christopher P Rusconi (8 out of 24 patents)

Douglas Brooks (3 out of 6 patents)

Juliana Layzer (3 out of 6 patents)

4. Steven Zelenkofske (3 out of 3 patents)

Please report any incorrect information to support@idiyas.com

1 patent (EPO):

Please report any incorrect information to support@idiyas.com